JPH11513037A - 非ステロイド抗炎症剤およびキサンチン誘導体の組み合わせを含有する局所用ゲル組成物 - Google Patents

非ステロイド抗炎症剤およびキサンチン誘導体の組み合わせを含有する局所用ゲル組成物

Info

Publication number
JPH11513037A
JPH11513037A JP10503550A JP50355098A JPH11513037A JP H11513037 A JPH11513037 A JP H11513037A JP 10503550 A JP10503550 A JP 10503550A JP 50355098 A JP50355098 A JP 50355098A JP H11513037 A JPH11513037 A JP H11513037A
Authority
JP
Japan
Prior art keywords
weight
composition according
acid
composition
derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP10503550A
Other languages
English (en)
Japanese (ja)
Inventor
ジョン リーヴス，ナイジェル
リアイ，フランソワ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Procter and Gamble Co
Original Assignee
Procter and Gamble Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter and Gamble Co filed Critical Procter and Gamble Co
Publication of JPH11513037A publication Critical patent/JPH11513037A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Inorganic Chemistry (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP10503550A 1996-06-27 1997-06-24 非ステロイド抗炎症剤およびキサンチン誘導体の組み合わせを含有する局所用ゲル組成物 Pending JPH11513037A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9613457.2A GB9613457D0 (en) 1996-06-27 1996-06-27 Pharmaceutical compositions
GB9613457.2 1996-06-27
PCT/US1997/011205 WO1997049405A1 (en) 1996-06-27 1997-06-24 Topical gel composition containing a combination of a nsaid and a xanthine derivative

Publications (1)

Publication Number Publication Date
JPH11513037A true JPH11513037A (ja) 1999-11-09

Family

ID=10795959

Family Applications (1)

Application Number Title Priority Date Filing Date
JP10503550A Pending JPH11513037A (ja) 1996-06-27 1997-06-24 非ステロイド抗炎症剤およびキサンチン誘導体の組み合わせを含有する局所用ゲル組成物

Country Status (14)

Country Link
EP (1) EP0973522A1 (no)
JP (1) JPH11513037A (no)
KR (1) KR20000022245A (no)
AU (1) AU3643897A (no)
BR (1) BR9709997A (no)
CA (1) CA2258199A1 (no)
CZ (1) CZ409198A3 (no)
GB (1) GB9613457D0 (no)
HU (1) HUP9903835A3 (no)
IL (1) IL127426A0 (no)
NO (1) NO986042L (no)
NZ (1) NZ333180A (no)
TR (1) TR199802701T2 (no)
WO (1) WO1997049405A1 (no)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7919125B2 (en) 2001-06-20 2011-04-05 Metaproteomics, Llc Modulation of inflammation by hops fractions and derivatives
US8158160B2 (en) 2001-11-13 2012-04-17 Eric Hauser Kuhrts Anti-inflammatory cyclooxygenase inhibitors

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6274592B1 (en) 1997-02-04 2001-08-14 Senju Pharmaceutical Co., Ltd. Method for stabilizing arylcarboxylic acid, stabilizer thereof and aqueous solution containing stabilized arylcarboxylic acid
HUP9802716A3 (en) * 1998-11-25 2000-08-28 Chinoin Gyogyszer Es Vegyeszet Pharmaceutical composition of analgesic activity
US6368618B1 (en) 1999-07-01 2002-04-09 The University Of Georgia Research Foundation, Inc. Composition and method for enhanced transdermal absorption of nonsteroidal anti-inflammatory drugs
US9012402B1 (en) 2014-06-11 2015-04-21 James Blanchard Gel for topical delivery of NSAIDs to provide relief of musculoskeletal pain and methods for its preparation
US10821075B1 (en) 2017-07-12 2020-11-03 James Blanchard Compositions for topical application of a medicaments onto a mammalian body surface

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4559343A (en) * 1982-09-07 1985-12-17 Alcon Laboratories, Inc. Nonirritating aqueous ophthalmic compositions comfort formulation for ocular therapeutic agents
US5558876A (en) * 1995-03-29 1996-09-24 Alcon Laboratories, Inc. Topical ophthalmic acidic drug formulations

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7919125B2 (en) 2001-06-20 2011-04-05 Metaproteomics, Llc Modulation of inflammation by hops fractions and derivatives
US8158160B2 (en) 2001-11-13 2012-04-17 Eric Hauser Kuhrts Anti-inflammatory cyclooxygenase inhibitors
US8846115B2 (en) 2001-11-13 2014-09-30 Metaproteomics, Inc. Anti-inflammatory cyclooxygenase inhibitors

Also Published As

Publication number Publication date
NZ333180A (en) 2000-09-29
KR20000022245A (ko) 2000-04-25
HUP9903835A2 (hu) 2000-10-28
HUP9903835A3 (en) 2001-03-28
EP0973522A1 (en) 2000-01-26
CA2258199A1 (en) 1997-12-31
TR199802701T2 (xx) 1999-03-22
BR9709997A (pt) 1999-08-10
AU3643897A (en) 1998-01-14
IL127426A0 (en) 1999-10-28
NO986042L (no) 1999-02-26
NO986042D0 (no) 1998-12-22
GB9613457D0 (en) 1996-08-28
WO1997049405A1 (en) 1997-12-31
CZ409198A3 (cs) 1999-04-14

Similar Documents

Publication Publication Date Title
AU2007311019B2 (en) Diclofenac gel
US8053000B2 (en) Compositions for drug delivery
US10328034B2 (en) Polymeric adhesive matrix with salified carboxylic groups for transdermal use
AU2013323766B2 (en) Topical ketoprofen composition
JP2001521887A (ja) Ｎｓａｉ薬送達用局所組成物
CN111904926B (zh) 局部用双氯芬酸钠组合物
JP2003507415A (ja) 経口液体組成物
JP2001508442A (ja) ポリマーを使用して粘度付与したヒドロアルコール組成物
JPH0338250B2 (no)
JPH05508840A (ja) 局所眼用懸濁液剤
JP2003525910A (ja) 抗感染活性成分配合物、ならびに足指および手指の真菌感染の処置におけるその使用
JPS63174924A (ja) 軟膏基剤および軟膏剤
JPH11513037A (ja) 非ステロイド抗炎症剤およびキサンチン誘導体の組み合わせを含有する局所用ゲル組成物
JP2942508B2 (ja) 温度感受性徐放性基剤及び温度感受性徐放性システム
US20080175810A1 (en) Topical compositions for cosmetic and pharmaceutical use
JP2012092067A (ja) 非ステロイド性消炎鎮痛外用剤
JP2000273016A5 (no)
JP3232810B2 (ja) 被膜形成型外用剤
JP3157082B2 (ja) 医療用パック型製剤用基剤および医療用パック型製剤
JPH06256168A (ja) 軟膏基剤およびそれを用いた歯周疾患治療用組成物
JPH09110702A (ja) 海洋深層水含有ゲル製剤
CN1223584A (zh) 含非类固醇抗炎药和黄嘌呤衍生物组合的局部外用的凝胶组合物
JP2936408B2 (ja) オキシカム系抗炎症剤の外用剤
Zalivskaya et al. Comparative characteristics of gel bases for semisolid dosage forms
JP3527103B2 (ja) メトトレキサート経皮適用剤